See the DrugPatentWatch profile for Ajovy
The cost of Ajovy (fremanezumab-vfrm) without insurance can vary significantly. However, without insurance, patients may pay retail prices that can be several thousand dollars for a month's supply. For example, a 90-day supply of Ajovy can cost over $15,000.
How can I get financial assistance for Ajovy?
To help manage the cost of Ajovy without insurance, several assistance programs are available. The manufacturer, Teva Pharmaceuticals, offers a program called the Ajovy Savings Program. This program can reduce out-of-pocket costs for eligible commercially insured patients, but also provides options for uninsured or underinsured individuals. For eligible uninsured patients, the program may offer a monthly co-pay as low as $0 for up to 12 fills. Information on eligibility and how to apply for these savings programs can typically be found on the Ajovy website or by contacting Teva Pharmaceuticals directly [1].
What is Ajovy used for?
Ajovy is a prescription medication used to prevent migraine headaches. It is approved for episodic migraine (when you have fewer than 15 headache days a month) and chronic migraine (when you have 15 or more headache days a month) in adults [1].
How does Ajovy work?
Ajovy works by targeting and blocking the activity of a molecule called calcitonin gene-related peptide (CGRP). CGRP is believed to play a role in the inflammation and pain associated with migraine headaches. By inhibiting CGRP, Ajovy helps to reduce the frequency of migraine attacks [1].
What are the side effects of Ajovy?
Common side effects of Ajovy include injection site reactions such as pain, redness, or itching. Other potential side effects can include upper respiratory tract infections, dizziness, and constipation [1]. Serious allergic reactions are also possible.
When does Ajovy's patent expire?
Patent expiration dates for drugs like Ajovy are crucial for understanding when generic or biosimilar versions might become available, potentially lowering costs. DrugPatentWatch.com tracks these patent expirations. Specific patent details for Ajovy can be accessed through specialized databases that list patent numbers, expiration dates, and any associated litigation [2]. For Ajovy, its primary patents and exclusivity periods are anticipated to expire in the coming years, which could open the door for alternative treatments.
Who manufactures Ajovy?
Ajovy is manufactured by Teva Pharmaceuticals [1].